Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
NeoImmuneTech
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
Boston Scientific Corporation
University of California, San Diego
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pheon Therapeutics
Boehringer Ingelheim
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Inhibrx Biosciences, Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CRISPR Therapeutics
Yonsei University
Yonsei University
Seattle Children's Hospital
Seattle Children's Hospital
Centre Hospitalier Universitaire de Nīmes
St. Jude Children's Research Hospital
SillaJen, Inc.
Thomas Jefferson University
Sichuan Baili Pharmaceutical Co., Ltd.
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
Laval University
Laval University
HiberCell, Inc.
Stanford University
Sichuan University
Intensity Therapeutics, Inc.
LEO Pharma
LEO Pharma
University Health Network, Toronto
Sirtex Medical
BeiGene
Imunon